Literature DB >> 11477555

Overexpression of homeobox gene HOXD3 induces coordinate expression of metastasis-related genes in human lung cancer cells.

T Omatsu, F Okada, K Furuuchi, Y Okubo, Y Takahashi, M Tada, Y J Miyazaki, Y Taniguchi, H Shirato, K Miyasaka, T Moriuchi.   

Abstract

Homeobox-containing genes are expressed in spatiotemporal fashion during embryogenesis and act as master transcription-regulating factors which control the expression of a variety of genes involved in morphogenesis. They are also expressed in a tissue-specific manner in normal adult tissues and appear to give cells spatial information in the maintenance of their architectural integrity. We transfected a HOXD3 class I homeobox-containing gene into human lung cancer A549 cells and investigated alterations in gene expressions and phenotypes related to the maintenance of tissue architecture in HOXD3-overexpressing A549 cells. In the HOXD3-overexpressing cell lines, expression of E-cadherin was lost and plakoglobin was strongly repressed, whereas integrin alpha3 and beta3 were up-regulated and N-cadherin and integrin alpha4 were newly expressed. Compared with parental and control transfectant lines, the HOXD3-overexpressing cell lines showed highly motile and invasive activity. Blocking experiments using anti-integrin beta1 and beta3 suggested that the increased haptotaxis of the HOXD3-overexpressing cells to vitronectin resulted from increased expression and activation of integrin alphavbeta3, and that overexpression of the HOXD3 gene converted the integrin beta1-dependent haptotaxis to fibronectin into both integrin beta1- and beta3-dependent one. HOXD3 overexpression increased production of matrix-degrative enzymes including matrix metalloproteinase-2 and urokinase-plasminogen activator. When the tumor cells were intravenously injected into the tail veins of nude mice, HOXD3 transfectants formed a significantly large number of metastatic foci in lungs compared with the control transfectants. These findings suggest that HOXD3 can act as a metastasis-promoting gene in human lung cancer A549 cells. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11477555     DOI: 10.1002/ijc.1357

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  29 in total

1.  HOXA5 regulates hMLH1 expression in breast cancer cells.

Authors:  Sai Duriseti; Paul T Winnard; Yelena Mironchik; Farhad Vesuna; Ana Raman; Venu Raman
Journal:  Neoplasia       Date:  2006-04       Impact factor: 5.715

Review 2.  Embryonic reversions and lineage infidelities in tumour cells: genome-based models and role of genetic instability.

Authors:  Leon P Bignold
Journal:  Int J Exp Pathol       Date:  2005-04       Impact factor: 1.925

3.  Enforced expression of the transcription factor HOXD3 under the control of the Wnt1 regulatory element modulates cell adhesion properties in the developing mouse neural tube.

Authors:  Yasushi Taniguchi; Osamu Tanaka; Masaki Sekiguchi; Susumu Takekoshi; Hideo Tsukamoto; Minoru Kimura; Kenji Imai; Hidetoshi Inoko
Journal:  J Anat       Date:  2011-09-16       Impact factor: 2.610

4.  Hox5 genes direct elastin network formation during alveologenesis by regulating myofibroblast adhesion.

Authors:  Steven M Hrycaj; Leilani Marty-Santos; Cristina Cebrian; Andrew J Rasky; Catherine Ptaschinski; Nicholas W Lukacs; Deneen M Wellik
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-22       Impact factor: 11.205

5.  Transduction of HOXD3-antisense into human melanoma cells results in decreased invasive and motile activities.

Authors:  Yoshiko Okubo; Jun-ichi Hamada; Yoko Takahashi; Mitsuhiro Tada; Arata Tsutsumida; Keiji Furuuchi; Tetsuya Aoyama; Tsuneki Sugihara; Tetsuya Moriuchi
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

6.  Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth.

Authors:  Douglas S Micalizzi; Chu-An Wang; Susan M Farabaugh; William P Schiemann; Heide L Ford
Journal:  Cancer Res       Date:  2010-11-05       Impact factor: 12.701

7.  An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition.

Authors:  Laetitia Seguin; Shumei Kato; Aleksandra Franovic; M Fernanda Camargo; Jacqueline Lesperance; Kathryn C Elliott; Mayra Yebra; Ainhoa Mielgo; Andrew M Lowy; Hatim Husain; Tina Cascone; Lixia Diao; Jing Wang; Ignacio I Wistuba; John V Heymach; Scott M Lippman; Jay S Desgrosellier; Sudarshan Anand; Sara M Weis; David A Cheresh
Journal:  Nat Cell Biol       Date:  2014-04-20       Impact factor: 28.824

8.  Silencing of IQGAP1 by shRNA inhibits the invasion of ovarian carcinoma HO-8910PM cells in vitro.

Authors:  Pei-Xin Dong; Nan Jia; Zhu-Jie Xu; Ying-Tao Liu; Da-Jin Li; You-Ji Feng
Journal:  J Exp Clin Cancer Res       Date:  2008-11-27

9.  Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays.

Authors:  Ken Kron; Vaijayanti Pethe; Laurent Briollais; Bekim Sadikovic; Hilmi Ozcelik; Alia Sunderji; Vasundara Venkateswaran; Jehonathan Pinthus; Neil Fleshner; Theodorus van der Kwast; Bharati Bapat
Journal:  PLoS One       Date:  2009-03-13       Impact factor: 3.240

10.  Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway.

Authors:  Peixin Dong; Zhujie Xu; Nan Jia; Dajin Li; Youji Feng
Journal:  Mol Cancer       Date:  2009-11-16       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.